Debate Series - Estro-events.org

E-posTErs
E-Posters
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung
Page 270 PROgRammE & ExhibiTiOn guidE • ESTRO 31
abS. numbER
> Treatment and outcomes of malignant tumors of external and
middle ear: a single institutional experience of 43 cases
A.K. Gandhi (India), A. Biswas, T. Saxena, P. Chaudhari, S. Roy,
A. Thakkar, A. Sharma, B.K. Mohanti EP-1194
> Dosimetric impact of volumes changes on IMRT H&N treatments in
light of patient setup errors
M. Herraiz Lablanca (Spain), A. Gutiérrez, N. Papanikolaou,
J. Hernández Armas EP-1195
> Analysis of weight management and acute dysphagia toxicity in
head and neck IMRT
N. Anderson (Australia), M. Rolfo, M. Wada, M. Schneider-Kolsky,
D. Lim Joon, V. Khoo EP-1196
> Parameters influencing RapidArc planning quality metrics in the
treatment of nasopharyngeal cancer
E. Khawandanah (Saudi Arabia), Y. Khan, Y. Albarakati, N. Mail,
N. Safadi, S. Al-Ghamdi, A. Saoudi EP-1197
> Nasopharyngeal cancer treated with accelerated radiotherapy in
combination with nimorazol and weekly cisplatinum
J. Bentzen (Denmark), J. Johansen, C.A. Kristensen, K. Jensen,
L. Andersen, K. Kiss, J. Overgaard EP-1198
> Topography of cervical lymph node metastases from oropharyngeal
carcinoma and selective radiotherapy
M. Martínez-Carrillo (Spain), I. Tovar Martin, N. Rodríguez-Ibarria,
P. Vargas-Arrabal, M. Gentil-Jiménez, I. Linares-Galiana,
R. Del Moral-Ávila, R. Guerrero-Tejada, M. Zurita-Herrera,
J. Expósito-Hernández EP-1199
> Smoking and Epstein-Barr virus IgA antibodies
(a marker for nasopharyngeal carcinoma) in Singapore Chinese
J. Friborg (Denmark), J.M. Yuan, W.P. Koh, R. Wang, S.H. Chan,
M. Melbye, M.C. Yu EP-1200
E-Posters
abS. numbER
> Late toxicity and health-related quality of life in locally advanced
head and neck cancer treated with RCT after ICT
R. Martínez (Spain), A. Ruíz, S. Rodríguez, N. Gascón, M.T. Murillo,
M.A. Pérez, A. Bartolomé, J.F. Pérez-Regadera, R. Díaz, E. Lanzós EP-1201
> Nasopharyngeal cancer and p16 expression: a new disease entity
arising in Caucasian patients?
C. Connolly (United Kingdom), P. Sanghera, J. Glaholm, A. Hartley EP-1202
> Prediction of early response to radiation therapy using FDG-PET
standard uptake value
A. Ruiz (Spain), R. D’Ambrosi, A. Castaño, R. De Juan, P. Cotrina,
P. Sarandeses, S. Guardado, J. Pérez-Regadera, M. Colmenero,
E. Lanzós EP-1203
> Markers of treatment outcome for patients with head and neck
cancer who underwent radiotherapy
T. Rutkowski (Poland), J. Mrochem-Kwarciak, A. Hajduk,
A. Wygoda, B. Lukaszczyk-Widel, M. Hutnik, W. Przeorek,
B. Maslyk, B. Hejduk, K. Skladowski EP-1204
> Function preservation with multimodality therapy in loco-regionally
advanced oral tongue cancer
H. Iqbal (Pakistan), A. Jamshed, R. Hussain, T. Mehmood, K. Saeed,
T. Sadaf, A. Loya EP-1205
> Carotid dosimetry for T1 glottic cancer radiotherapy
C.C. Lim (United Kingdom), K.F. Ho, R. Swindell, P. Whitehurst,
M. Lowe, B. Yap, L.W. Lee, A.J. Sykes, N.J. Slevin EP-1206
> Benefit of systematic RapidArc re-planning and adaptive treatment
of nasopharyngeal cancer
M. Khan (Saudi Arabia), N. Safadi, S. Al-Ghamdi, N. Mail, A. Saoudi EP-1207
> Toxicity and survival outcomes of nasopharyngeal cancers treated
by chemo- IMRT in a phase II trial
P. Lal (United Kingdom), A. Miah, S. Bhide, M.T. Guerrero-Urbano,
K. Newbold, K. Harrington, C. Nutting EP-1208
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 271
E-posTErs
eSTRO 31